BioMARC's Grant

BioMARC raised a round of funding on February 28, 2017. Investors include U.S. Department of Defense.

BioMARC is developing a drug to protect U.S. soldiers from a mosquito-borne pathogen that can cause severe illness and death.…

Articles about BioMARC's Grant: